NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Total Debt | ₹123 Cr | ₹110 Cr | ₹105 Cr | ₹93 Cr | ₹19 Cr |
What is the latest Total Debt ratio of NATH BIOGENES (INDIA) ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹123 Cr |
| Mar2024 | ₹110 Cr |
| Mar2023 | ₹105 Cr |
| Mar2022 | ₹93 Cr |
| Mar2013 | ₹19 Cr |
How is Total Debt of NATH BIOGENES (INDIA) Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹123 Cr | 11.02 | |
| Mar2024 | ₹110 Cr | 4.88 | |
| Mar2023 | ₹105 Cr | 13.18 | |
| Mar2022 | ₹93 Cr | 382.98 | |
| Mar2013 | ₹19 Cr | - | |
Compare Total Debt of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹275.7 Cr | 0.8% | -5.6% | -5.7% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,949.0 Cr | -3.3% | -13.1% | -10.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,119.2 Cr | 6.8% | -10.7% | -24.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,767.5 Cr | -2.3% | -14.4% | -21.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹885.6 Cr | -0.5% | -9.2% | -39.7% | Stock Analytics | |
| INDO US BIOTECH | ₹198.5 Cr | -12.3% | -26.6% | -49% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 0.8% |
-5.6% |
-5.7% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses